ClinicalTrials.gg
Sign In

Hyperaldosteronism clinical trials

The registry lists 201 studies for Hyperaldosteronism across more than 10 countries. 93 are recruiting or about to start. 160 of them are mainly about Hyperaldosteronism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Hyperaldosteronism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
74
Recruiting
70
Status unknown
22
Not yet recruiting
19
Active, not recruiting
8
Enrolling by invitation
4

Phase

Phase 2
18
Phase 4
16
Phase 3
6
Phase 1
3
Early Phase 1
1

Where

China
77
United States
19
United Kingdom
16
France
14
Italy
13
Canada
10

Who runs them

Chongqing Medical University (13) · Third Military Medical University (10) · Qifu Li (8) · University Hospital Padova (7) · National Taiwan University Hospital (6) · Changi General Hospital (6) · Chinese Academy of Medical Sciences, Fuwai Hospital (5) · Xinjiang Medical University (5)

What is being tested here

Drugs under test in Hyperaldosteronism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Finerenone306
Eplerenone205
Amlodipine104
Baxdrostat113
Spironolactone102
Fluorine-18102
SYH2072101
SAL0140101
QLS1410101
Gallium-68101

Drug classes tested here Mineralocorticoid receptor antagonists (MRAs) 7 open · Calcium channel blockers 1 open

Coming up

2phase 3 studies under way
24studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 70 Hyperaldosteronism studies recruiting now, 23 (33%) set no upper age limit and 31 (44%) stop at 75 or younger. 7 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 14 (20%) take healthy volunteers.

Recruiting studies that take each age, of 70
AgeWomenMen
105 (7%)5 (7%)
1862 (89%)62 (89%)
3067 (96%)67 (96%)
4068 (97%)68 (97%)
5068 (97%)68 (97%)
6562 (89%)62 (89%)
7547 (67%)47 (67%)
8530 (43%)30 (43%)

Across all 201 studies, recruiting or not: 41% stop at 75 or younger and 14% at 65; 9% take children; <1% are for women only and <1% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperaldosteronism studies take

Of 64 observational studies under Hyperaldosteronism, half reached primary completion within 75 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo21–59 · 35 studies——
Observational75 mo32–96 · 64 studies—75 mo32–96 · 64 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Results posted1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 201. Browse all 201 → or search them.